Drug intelligence / Profile preview

physiological saline + N-acetylcysteine + sodium bicarbonate

Development stage
Unknown
Modality
Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Intravenous
01

Overview

This is a combination therapy consisting of physiological saline (isotonic sodium chloride solution), N-acetylcysteine, and sodium bicarbonate. The regimen is primarily used as a prophylactic intervention to prevent contrast-induced acute kidney injury (CI-AKI) in patients undergoing procedures involving iodinated contrast media, such as coronary angiography or percutaneous coronary interventions. - **Physiological saline** provides volume expansion and maintains renal perfusion. - **N-acetylcysteine** acts as an antioxidant, scavenging free radicals and potentially reducing oxidative stress in renal tubular cells. - **Sodium bicarbonate** alkalinizes urine, which may reduce the formation of reactive oxygen species associated with contrast-induced nephropathy. The mechanism involves synergistic effects on reducing oxidative damage to the kidneys by combining hydration (saline), antioxidant action (N-acetylcysteine), and pH modulation (sodium bicarbonate). Clinical studies have shown mixed results regarding efficacy; some meta-analyses suggest a reduction in CI-AKI incidence compared to monotherapy or hydration alone[1][3][6], while other large trials found no significant benefit over standard care[7]. This combination does not have a unique brand name or code name and is typically prepared for use in hospital settings.

Other names
NAC + sodium bicarbonate + salineIntravenous high-dose N-acetylcysteine and sodium bicarbonate
02

Targets

ROS (Reactive oxygen species and electrophilic radicals)

Beyond the preview

Go deeper on physiological saline + N-acetylcysteine + sodium bicarbonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on physiological saline + N-acetylcysteine + sodium bicarbonate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call